Saudi Arabia’s National Unified Procurement Co. (NUPCO) on Sunday awarded Pharma Serve, a subsidiary of Al Hammadi Company for Development and Investment, a two-year contract worth SAR 347 million to provide vaccines to government health authorities.
Pharma Serve is a wholly-owned subsidiary of Medical Support Services Company, which in turn is a subsidiary of Al Hammadi.
The deal’s financial impact is expected to show on Al Hammadi’s Q3 resultsthe Saudi healthcare firm said in a statement on Tadawul.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}